We identify calcium-permeable ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors on human neural progenitor cells (NPCs) and present a physiological role in neurogenesis. RNA editing of the GluR2 subunit at the Q/R site is responsible for making most AMPA receptors impermeable to calcium. Because a single-point mutation could eliminate the need for editing at the Q/R site and Q/R-unedited GluR2 exists during embryogenesis, the Q/R-unedited GluR2 subunit presumably has some important actions early in development. Using calcium imaging, we found that NPCs contain calcium-permeable AMPA receptors, whereas NPCs differentiated to neurons and astrocytes express calcium-impermeable AMPA receptors. We utilized reverse-transcription polymerase chain reaction and BbvI digestion to demonstrate that NPCs contain Q/R-unedited GluR2, and differentiated cells contain Q/R-edited GluR2 subunits. This is consistent with the observation that the nuclear enzyme responsible for Q/R-editing, adenosine deaminase (ADAR2), is increased during differentiation. Activation of calciumpermeable AMPA receptors induces NPCs to differentiate to the neuronal lineage and increases dendritic arbor formation in NPCs differentiated to neurons. AMPAinduced differentiation of NPCs to neurons is abrogated by overexpression of ADAR2 in NPCs. This elucidates the role of AMPA receptors as inductors of neurogenesis and provides a possible explanation for why the Q/R editing process exists.-Whitney, N. P., Peng, H., Erdmann, N. B., Tian, C., Monaghan, D. T., Zheng, J. C. Calciumpermeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons. FASEB J. 22, 2888 -2900 (2008)
␣-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors are ionotropic glutamate receptors that mediate the majority of fast excitatory neurotransmission in the mammalian central nervous system (CNS) (1, 2) . AMPA receptors are composed of GluR1, 2, 3, and 4 subunits in a tetraheteromeric complex, with the vast majority of AMPA receptors containing GluR2 subunits (3) (4) (5) . Incorporation of GluR2 subunits typically renders AMPA receptors impermeable to calcium (6 -9) . Calcium impermeability is a consequence of editing at the Q/R site of GluR2 pre-mRNA in which a gene-encoded glutamine (Q) codon in the channelforming intramembrane segment is changed to an arginine (R) codon (7, 8, 10, 11) . This Q/R editing is mediated by the enzyme adenosine deaminase (ADAR2), which edits nearly 100% of GluR2 pre-mRNA in the adult CNS (10, 12, 13) . Q/R editing is necessary for survival, as demonstrated by Higuchi et al. (12) , who showed that a mouse ADAR2 knockout was fatal. Transgenic replacement of edited GluR2, substituting an arginine in the Q/R editing site, restored viability. Although unedited GluR2 has been identified (14 -17) , a physiological role for this type of receptor has not yet been identified.
Neurogenesis is dependent on the proper proliferation, migration, differentiation, and survival of neural progenitor cells (NPCs) (18, 19) . NPCs are self-renewing multipotent cells capable of differentiating into neurons, astrocytes, and oligodendrocytes (18, 20) . l-Glutamate (Glu) is a key factor influencing neurogenesis (21, 22) , an effect mediated in part by AMPA receptors. Potentiation of AMPA receptors has been shown to increase cell proliferation in the adult rat hippocampus (23) , enhance performance of rats in cognitive assays (24, 25) , and increase brain-derived neurotrophic factor (BDNF) expression in the dentate gyrus of the rat hippocampus (26) . We sought to characterize the nature of the Glu-mediated neurogenesis and to determine the effects of Glu on NPC function. Here, we describe Glu stimulation in cultured NPCs directing differentiation to the neuronal lineage.
We observed that Glu stimulation induced calcium influx in NPCs that lacked functional N-methyl-d-aspartate (NMDA) receptor expression but expressed AMPA receptors. NPCs expressed significant amounts of Q/Runedited GluR2 subunits, identifying a population of cells expressing calcium-permeable AMPA receptors. Activation and potentiation of calcium-permeable AMPA receptors induced differentiation of NPCs to neurons and stimulated dendritic arbor formation. NPCs differentiated to astrocytes and neurons expressed AMPA receptors with Q/R-edited GluR2 subunits, and Q/R editing during differentiation correlated with an increase in the expression of ADAR2. Overexpression of ADAR2 in NPCs resulted in the increase of Q/R-edited GluR2 and prevented AMPAmediated differentiation to neurons. In identifying a physiological role for these calcium-permeable AMPA receptors, we present a feasible explanation for the existence of Q/R-unedited GluR2 subunits and the Q/R-editing process.
MATERIALS AND METHODS

Human fetal NPC, differentiated neuron, and differentiated astrocyte culture
Human fetal NPCs were isolated from human fetal brain tissue (gestational age 13-16 wk) from elective aborted specimens as described previously (27) , in full compliance with University of Nebraska Medical Center (UNMC) and U.S. National Institutes of Health (NIH) ethical guidelines. Briefly, NPCs were cultured in substrate-free tissue culture flasks and grown in suspension in neurosphere initiation medium (NPIM), which consisted of X-Vivo 15 (BioWhittaker, Walkersville, ME, USA) with N2 supplement (Gibco Invitrogen Corporation, Carlsbad, CA, USA), basic fibroblast growth factor (bFGF; 20 ng/ml; Sigma-Aldrich, St. Louis, MO, USA), epidermal growth factor (EGF; 20 ng/ml; SigmaAldrich), leukemia inhibitory factor (LIF; 10 ng/ml; Chemicon, Temecula, CA, USA), neural cell survival factor-1 (NSF-1; Cambrex BioScience, Walkersville, MD, USA), and 60 ng/ml N-acetylcysteine (Sigma-Aldrich) (28) . NPCs were passaged at 2-wk intervals as described previously (27) and utilized between passages 4 and 14. After a 15-min trypsin incubation and mechanical disassociation of NPCs, 2 ϫ 10 6 NPCs for astrocyte differentiation and 5 ϫ 10 6 NPCs for neuron differentiation were plated in poly-d-lysine-coated T75 flasks. NPCs are differentiated to neurons in neuron differentiation medium, which consists of neurobasal medium with B27 supplement (Gibco Invitrogen), 100 IU/ml penicillin/streptomycin, and 500 M lglutamine. NPCs are differentiated to astrocytes in astrocyte differentiation medium, which consists of Dulbecco's modified eagle medium with F12 (Gibco Invitrogen), 10% fetal bovine serum, 100 IU/ml penicillin/streptomycin, and fungizone.
RNA extraction and TaqMan real-time reverse-transcription polymerase chain reaction (RT-PCR)
Total RNA was isolated with TRIzol Reagent (Invitrogen) and RNeasy Mini Kit according to the manufacturer's protocol (Qiagen, Valencia, CA, USA). Assay-on-Demand primers for GluR1 (Hs00181348_m1), GluR2 (Hs00181331_m1), GluR3 (Hs00241485_m1), GluR4 (Hs00168163_m1), ADAR2 (Hs00210562_m1), and GAPDH (4310884E) were purchased from Applied Biosystems (Foster City, CA, USA). Real-time RT-PCR was carried out using the one-step quantitative TaqMan Real-time RT-PCR system (Applied Biosystems). Relative GluR1-4 and ADAR2 levels were determined and standardized with GAPDH as an internal control.
Immunocytochemistry
Cells were fixed using 1:1 acetone/methanol for 20 min at Ϫ20°C, after which the acetone/methanol was removed, and the cells were allowed to air dry and then were rehydrated with PBS. Cells were blocked for 1 h with 0.1% Triton X-100 and 2% BSA in PBS and incubated overnight at 4°C with primary antibodies in PBS with 0.1% Triton X-100 and 2% BSA. Secondary antibodies, Alexa Fluor 488 (green) and 594 (red) (Molecular Probes Invitrogen, Carlsbad, CA, USA) were applied for 1 h at room temperature, and then stained with Hoechst 33342 for 20 min. The primary antibodies used were anti-GluR1 (polyclonal, 2.0 g/ml; Chemicon), anti-GluR2 (monoclonal, 2.0 g/ml; Chemicon), anti-GluR3 (monoclonal, 2.0 g/ml; Chemicon), anti-GluR4 (polyclonal, 2.0 g/ ml; Chemicon), nestin (polyclonal, 1:100, Chemicon; monoclonal, 5.0 g/ml, R&D Systems, Minneapolis, MN, USA), anti-␤-tubulin isotype III (monoclonal, 1:400; Sigma-Aldrich), and anti-glial fibrillary acidic protein (GFAP) (polyclonal, 1:1000; DAKO, Carpinteria, CA, USA).
Protein extraction and Western blot analysis
Nuclear proteins were extracted using NE-PER nuclear and cytoplasmic extraction reagents (Pierce, Rockford, IL, USA), and total protein was isolated using M-PER mammalian protein extraction reagent (Pierce) according to the manufacturer's protocol. Proteins were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and electrophoretically transferred to an Immobilon-P membrane (polyvinyldifluoridene membranes) (BioRad, Hercules, CA, USA). Membranes were incubated with primary antibodies for ADAR2 (1:50; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and loading control ␤-actin (1:10,000; Sigma-Aldrich) or Tata box binding protein (TBP) (1:2,000; Abcam, Cambridge, MA, USA) overnight at 4°C, followed by a horseradish peroxidase-linked secondary antimouse antibody (1:10,000; Cell Signaling Technologies, Danvers, MA, USA) or anti-goat antibody (1:10,000; Santa Cruz Biotechnology) for 1 h at room temperature. Antigen-antibody complexes were visualized by enhanced chemiluminescence Western blot analysis and captured with Hyperfilm ECL (Pierce), and immunoblot images were quantified using NIH Image 1.63 (NIH, Bethesda, MD, USA).
Calcium imaging
NPCs (2ϫ10 5 )were plated into 6-well plates with poly-d-lysinecoated 25-mm glass coverslips in NPIM, neuron differentiation medium, or astrocyte differentiation medium. Calcium imaging was performed on NPCs between 1 and 3 days after plating; differentiated neurons and astrocytes were used between 4 and 6 wk after plating. Medium was removed, and cells were loaded with 7 M Fura-II AM (Molecular Probes, Eugene, OR, USA) in calcium buffer (145 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, and 10 mM glucose) with 0.018% pluronic acid (Molecular Probes) and 0.09% dimethyl sulfoxide (DMSO) for 30 -60 min at 37°C. Cells were rinsed 4 times with calcium buffer, mounted into a perfusion chamber, and perfused with the calcium buffer or calcium-free buffer (CaCl 2 was omitted and 3 mM EGTA was added). A field including 15-20 cells was selected, and the change in intracellular calcium level was measured by monitoring the excitation intensity at 340 and 380 nm wavelengths using a photometer (Photon Technology International, London, ON, Canada) coupled to an inverted Nikon TMD Diaphot epifluorescent microscope (Nikon, Melville, NY, USA) as described previously (29) . The intracellular calcium concentrations were calculated as follows: [Ca 2ϩ 
(380 min /380 max ), where R min and R max are the fluorescence ratios in the absence (with 3 mM EGTA) or presence of saturating calcium (3 mM), respectively, and K d ϭ 224 nM.
Q/R editing assay
Nested PCR products containing the Q/R editing site were digested with BbvI as described previously (13) . cDNA (50 ng) was subjected to PCR in a 50-l reaction containing 5 l 10ϫ PCR buffer with MgCl 2 (Roche Applied Science, Indianapolis, IN, USA), 0.8 mM dNTP mix (Applied Biosystems), 0.25 l TaqDNA polymerase (Roche Applied Science), and 200 M primer. The PCR amplification protocol was 95°C for 2 min, followed by 36 cycles of 95°C for 30 s, 64°C for 30 s, and 72°C for 1 min, and finished with a final extension of 72°C for 7 min. The primers used for the first-round reaction were forward (5Ј-TTCCTGGTCAGCATTTAGCC-3Ј) and reverse (5Ј-TTCCCTTTGGACTTCCGCAC-3Ј), and for the secondround reaction, the primers used were the same forward and a second reverse (5Ј-TGGGAGACACCATCCTCTCTACA G-3Ј) (13). A nested PCR was then performed on 2 l of the first-round product in a 100-l reaction containing 10 l of 10ϫ PCR buffer with MgCl 2 (Roche Applied Science), 0.8 mM of dNTP mix (Applied Biosystems), 0.5 l of TaqDNA polymerase (Roche Applied Science), and 200 M of primer. PCR products were run on a 1% agarose gel; the 277-bp band (the expected size of the second-round PCR product) was excised and gel purified using a QIAquick Gel Extraction Kit (Qiagen), according to the manufacturer's protocol, yielding 48 -50 l of product. The gel-purified product was digested with BbvI overnight at 37°C, and digested products were run on a 2.5% agarose gel. The products were visualized and photographed with a UVP Transilluminator (UVP Inc., Upland, CA, USA), the bands were quantified with NIH Image 1.63, and the percentage of unedited GluR2 was calculated by comparing the relative intensities of the 228 and the sum of 147-and 81-bp bands.
Differentiation assay
NPCs were plated into 24-well poly-d-lysine-coated plates at a concentration of 5 ϫ 10 4 cells/well ( Fig. 1 ) or 1 ϫ 10 5 ( Fig.  6 ) in neuron differentiation medium. Cells were treated after plating with control neuron differentiation medium alone or with progressive addition of 10 M l-glutamate, 10 M cyclothiazide, and 30 M MK-801 or 10 M CNQX (Fig. 1) ; or control neuron differentiation medium alone or with progressive addition of 3 M AMPA, 10 M cyclothiazide, and 10 M 1-napthyl acetyl spermine (Naspm) in the presence of 0.1% DMSO (Fig. 6 ). After 1 wk, cells were stained for GFAP, ␤-tubulin-III and Hoechst 333342. Ten (Fig. 1 ) or 15 pictures per condition (Fig. 6 ) were taken at ϫ200, and the numbers of neurons and astrocytes for each condition were manually counted: control, 10 M l-glutamate, 10 M l-glutamate with 10 M cyclothiazide, 10 M l-glutamate with 10 M cyclothiazide and 30 M MK-801, and 10 M l-glutamate with 10 M cyclothiazide and 10 M CNQX (Fig. 1) ; or control, 3 M AMPA, 3 M AMPA with 10 M cyclothiazide, and 3 M AMPA with 10 M cyclothiazide and 10 M Naspm (Fig. 6) . The data are expressed as the percentage of neurons or astrocytes; representative pictures are shown for each condition.
Dendritic arbor quantification
Dendritic arborization was quantified as described previously (30) . Briefly, NPCs were plated into 24-well plates with 12-mm poly-d-lysine-coated coverslips at a concentration of 5 ϫ 10 4 cells/well in neuron differentiation medium. Cells were treated after plating with control neuron differentiation medium alone or with progressive addition of 3 M AMPA, 10 M cyclothiazide, and 10 M Naspm. After 1 wk in culture, the cells were stained for GFAP, ␤-tubulin-III, and Hoechst. Five pictures per condition were taken at ϫ200, and numbers of neurites per cell, arbors per cell, branch nodes per cell, and average arbor length were calculated for neurons not physically associated with astrocytes for each condition: control, 3 M AMPA, 3 M AMPA with 10 M cyclothiazide; and 3 M AMPA with 10 M cyclothiazide and 10 M Naspm.
Electroporation
NPCs were transfected with recombinant pECFP-ADAR2 plasmid (CFP-ADAR2) (generously provided by Dr. Andrew MacMillan, University of Alberta, Edmonton, AB, Canada) and pECFP-N1 alone using a basic nucleofector kit for primary mammalian neurons (Amaxa, Gaithersburg, MD, USA). NPCs (5ϫ10 6 ) were suspended in 100 M nucleofector solution with 8 g recombinant plasma or empty vector. Electroporation was preformed using the Amaxa nucleofector device (Amaxa, Gaithersburg, MD, USA) and nucleofector program A-033.
Statistical analysis
Data are expressed as means Ϯ se. The data were evaluated statistically by analysis of variance (ANOVA), followed by the Tukey test for paired observations. Significance was considered to be P Ͻ 0.05.
RESULTS
Glutamate induces differentiation of NPCs to neurons
Using our human NPC culture, which is Ͼ90% nestin positive (27) , we determined the effect of Glu on NPC differentiation. NPCs were cultured in neuronal differentiation medium for 7 days, and then they were stained for ␤-tubulin-III, GFAP, and Hoechst. NPCs were treated with neuronal differentiation medium alone (Fig. 1A) ; Glu (Fig. 1B) ; Glu and cyclothiazide (cyclo, an AMPA receptor-specific potentiator; (Fig. 1F) . Treatment with only cyclo, MK-801, or CNQX had no significant effect (data not shown). Chronic stimulation with Glu caused a significant increase (PϽ0.001) in the number of NPCs that differentiated to neurons. Neuronal differentiation was increased by the AMPA receptor-specific potentiator, cyclo (PϽ0.001), blocked by the AMPA/ kainate receptor antagonist, CNQX (PϽ0.001), but not prevented by the NMDA receptor antagonist, MK-801 (Fig. 1F) . These findings suggest that Glu-induced differentiation of NPCs to neurons is dependent on the activation of non-NMDA receptors.
AMPA receptor expression on NPCs, differentiated neurons, and differentiated astrocytes
NPCs were differentiated in culture to a predominant neuronal culture (N-diff) or astrocyte culture (A-diff). A majority of ␤-tubulin-III-positive (␤-tubulin ϩ ) cells was induced by serum-free neurobasal medium supplemented with B27. A majority of GFAP-positive (GFAP ϩ ) cells was induced by DMEM/F12 with 10% fetal bovine serum. Real-time RT-PCR was used to determine the expression pattern of AMPA receptor subunits in NPCs, N-diff cells, and A-diff cells. The results were standardized with GAPDH as an internal control. AMPA receptor subunits GluR1, 2, 3, and 4 mRNA (nϭ5 donors) were present in NPCs, N-diff cells, and A-diff cells ( Fig.  2A) . GluR1 and GluR2 subunits are preferred binding partners in the heteromeric receptor assembly (31) (32) (33) . To confirm the expression of AMPA receptor subunit protein, GluR1 and GluR2 were demonstrated with immunocytochemistry on NPCs (Fig. 2B-G) , N-diff cells (Fig. 2H-M) , and A-diff cells (Fig. 2N-S) . NPCs, N-diff cells, and A-diff cells were all shown to express GluR1 and GluR2 subunit protein.
NPCs contain calcium-permeable AMPA receptors
Using calcium imaging on groups of 20 NPCs, we found that 100 M Glu stimulation caused calcium influx. The observed calcium influx was greatly increased using the AMPA receptor-specific potentiator, cyclo, but was almost completely blocked using an AMPA/ kainate receptor antagonist, CNQX (Fig. 3A) . To more specifically test whether calcium-permeable AMPA receptors were responsible for the Glu-induced increase in intracellular calcium, we used an AMPA receptorspecific antagonist, Joro Spider toxin (Fig. 3B) , and a synthetic Joro Spider toxin analog, Naspm (Fig. 3C ). Both agents specifically block calcium-permeable AMPA receptors while minimally blocking calciumimpermeable AMPA receptors (34 -36) . Joro Spider toxin and Naspm eliminated the increases in intracellular calcium of Glu-stimulated NPCs. The use of calcium-free buffer eliminated the Glu response in NPCs, indicating the calcium response is dependent on extracellular calcium (data not shown). Furthermore, neither the NMDA receptor antagonist MK-801 (Fig.  3C) nor the voltage-gated ion channel blocker nimodipine (Fig. 3D) prevented glutamate-induced calcium influx. Thus, Glu-mediated calcium elevations in NPCs are primarily through calcium-permeable AMPA receptors and not through NMDA receptors, kainate receptors, voltage-gated ion channels, or intracellular stores.
Reduced expression of calcium-permeable AMPA receptors on differentiated neurons and astrocytes
After identifying calcium-permeable AMPA receptors on NPCs, we sought to determine whether calciumpermeable AMPA receptors were present on N-diff and A-diff cells. N-diff cells responded to Glu, and the calcium influx was amplified with cyclo (PϽ0.001; Fig. 4A ), suggesting that there may be calciumpermeable AMPA receptors on N-diff cells. However, Naspm failed to completely block the Glu and cycloinduced calcium influx (PϽ0.001; Fig. 4A ), demonstrating that calcium-permeable AMPA receptors are present on N-diff cells, but the calcium influx involves other receptors or channels. MK-801 prevented nearly 70% of the Glu-and cyclo-induced calcium influx (PϽ0.001; Fig. 4A ), suggesting that functional NMDA receptors are present. CNQX blocked 97% of the Glu and cyclo-induced calcium influx (PϽ0.001; Fig. 4A ). These findings indicate that the Glu-induced calcium influx in N-diff cells is likely through NMDA, kainate, and AMPA receptors. Most mature glutamatergic neurons express calcium-impermeable AMPA receptors; thus, it is likely that the presence of calcium-permeable AMPA receptors is due to immature neurons in the culture. Neurons not fully differentiated may still possess some features of NPCs, such as calcium-permeable AMPA receptors.
A-diff cultures were stimulated with 100 M Glu and 10 M cyclo. A-diff cultures exhibited no calcium influx when stimulated by Glu and cyclo but did respond to ATP-positive control, demonstrating the viability of the cells (Fig. 4B) . These results indicate that A-diff cells no longer express calcium-permeable AMPA receptors.
NPCs express AMPA receptors with Q/R-unedited GluR2 subunits, and expression of Q/R-edited GluR2 and ADAR2 increases as NPCs differentiate AMPA receptors are generally impermeable to calcium, although small populations of GluR2-lacking AMPA receptors are calcium permeable. We observed substantial GluR2 expression on NPCs, leading to the hypothesis that the calcium permeability of AMPA receptors in NPCs is due to the presence of Q/R-unedited GluR2 subunits. We determined the amount of Q/R editing of GluR2 mRNA using nested RT-PCR and BbVI restriction enzyme digestion. As diagrammed in Fig. 5A , BbVI cuts Q/R-edited GluR2 cDNA once, creating two fragments (228 and 49 bp) and cuts Q/R-unedited GluR2 subunits into three fragments (147, 81, and 49 bp). The digestion fragments from NPCs and NPCs differentiated to neurons and astrocytes for 1, 2, and 4 wk were separated on an agarose gel and visualized with 
GAPDH (nϭ5) (A). NPCs (B-G), N-diff cells (H-M), and A-diff cells (N-S) were stained for nestin (B, E), ␤-tubulin-III (H, K), GFAP (N, Q), GluR1 (C, I, O) and GluR2 (F, L, R).
# P Ͻ 0.05, ## P Ͻ 0.01 vs. GluR1 on NPCs. Data are representative of 3 separate experiments with NPCs from 3 separate donors.
ethidium bromide (Fig. 5B) . The majority (61Ϯ2.5%) of GluR2 subunit mRNA was Q/R-unedited in NPCs, and the percentage of Q/R-unedited GluR2 subunits decreased as NPCs differentiated (Fig. 5C) .
Expression of ADAR2 increases as NPCs differentiate to neurons and astrocytes
Q/R editing of GluR2 is dependent on the enzyme ADAR2. ADAR2 mRNA levels were analyzed from NPCs and NPCs differentiated to neurons and astrocytes for 1, 2, and 4 wk (nϭ3) by real-time RT-PCR. The results were standardized with GAPDH and expressed as fold increase of mRNA relative to ADAR2 in NPCs. ADAR2 levels were elevated in differentiated cells as compared to NPCs. The expression of ADAR2 mRNA was upregulated in neurons (14-fold by 4 wk; Fig. 5D ) and upregulated in astrocytes (4-fold at 4 wk; Fig. 5E ). Nuclear protein from NPCs and isolated primary neurons and astrocytes were analyzed by Western blotting. ADAR2 protein was not detected in NPCs but was present in both neurons and astrocytes (Fig. 5F ). ADAR2 expression increases as NPCs differentiate, which correlates to the change in Q/R editing of the GluR2 subunit.
Stimulation and potentiation of AMPA receptors directs NPC differentiation to neurons
Intracellular calcium ions play a key role in cell differentiation (37); thus, we hypothesized that a possible role of calcium-permeable AMPA receptors on NPCs might be neurogenesis. NPCs were treated with neuron differentiation medium alone (Fig. 6A) , AMPA (Fig.  6B ), AMPA and cyclo (Fig. 6C) , or AMPA, cyclo, and Naspm (Fig. 6D ) for 7 days, and then stained for ␤-tubulin-III, GFAP, and Hoechst. The cells were counted and scored as neurons (GFAP ϩ/Ϫ /␤-tubulin ϩ cells) or astrocytes (GFAP ϩ /␤-tubulin Ϫ cells), and the data are expressed as percentage neurons (Fig. 6E ) and percentage astrocytes (Fig. 6F) . Treatment with cyclo or Naspm alone had no significant effect (data not shown). AMPA stimulation of NPCs caused a significant increase in differentiation of NPCs to neurons (PϽ0.001). This effect was enhanced by potentiating AMPA receptors with cyclo (PϽ0.001) and was completely blocked with the calcium-permeable AMPA receptor antagonist Naspm (PϽ0.001; Fig. 6E ). Therefore, activation of calcium-permeable AMPA receptors directed the differentiation of NPCs to the neuronal lineage. 
Stimulation and potentiation of AMPA receptors stimulate dendrite arbor formation in NPCs differentiated to neurons
Dendritic arborization is an important component of neurogenesis and correlates to successful integration of new neurons into the neuronal circuitry (38) . NPCs were treated with control neuron differentiation medium alone (Fig. 7A), AMPA (Fig. 7B ), AMPA and cyclo (Fig. 7C) , or AMPA, cyclo, and Naspm (Fig. 7D ) for 7 days, and then stained for ␤-tubulin-III, GFAP, and Hoechst. The numbers of neurites, arbors, and branch nodes per cell and the average arbor length were calculated for neurons not associated with astrocytes in 5 pictures per condition. Administration of cyclo or Naspm alone showed no significant effects on dendritic arborization (data not shown). Activation of AMPA receptors significantly increased the numbers of neurites per cell (Fig. 7E ), arbors per cell (Fig. 7F) and branch nodes per cell (Fig. 7G ) and the average arbor length (Fig. 7H) for N-diff cells. These effects were prevented by the AMPA antagonist Naspm, indicating calcium-permeable AMPA receptor stimulation-induced dendritic arborization.
Overexpression of ADAR2 prevents AMPA-induced differentiation of NPCs to neurons
Expression of Q/R-edited GluR2 subunits is essential to confirm that AMPA-induced neural differentiation of NPCs is dependent on activation of calcium-permeable AMPA receptors. Thus, we transfected NPC cultures with a vector containing ADAR2 cDNA with a cyan fluorescent protein tag (CFP-ADAR2) to induce premature ADAR2 expression and Q/R editing of GluR2 subunits. Expression of ADAR2 protein in NPCs was demonstrated by Western blot analysis (Fig. 8A) . ADAR2 expression in NPCs reduced the amount of Q/R-unedited GluR2 subunits (Fig. 8B) to levels comparable to A-diff cells (Fig. 5C ), resulting in a lack of calcium-permeable AMPA receptors (Fig. 8E) . Delivery of ADAR2 to NPCs prevented AMPA-induced neural differentiation of NPCs (Fig. 8F ). NPCs transfected with the CFP plasmid contained calcium-permeable AMPA receptors (Fig. 8C) and underwent typical AMPA-induced neural differentiation, as previously demonstrated in Fig. 6 (Fig. 8D) . AMPA or glutamate stimulation induces differentiation of NPCs to neurons by activation of calcium-permeable AMPA receptors. The overexpression of ADAR2, and resulting Q/R-edited GluR2, abrogates the effect of AMPA on NPC differentiation.
DISCUSSION
In this study, we identified human NPCs expressing calcium-permeable AMPA receptors that contain Q/Runedited GluR2 subunits. As NPCs matured and differentiated to neural or glial lineages, cells began to express calcium-impermeable AMPA receptors comprising Q/R-edited GluR2 subunits. The transition from unedited to edited GluR2 subunits correlated with increased ADAR2 expression. Stimulation of calciumpermeable AMPA receptors was found to steer the differentiation of NPCs to neuronal cells in favor of glial cells, and promoted dendritic arborization. Overexpression of ADAR2 in NPCs resulted in Q/R editing and the expression of calcium-impermeable AMPA receptors, which prevented AMPA-mediated differentiation to neurons. These findings suggest a physiological role for the Q/R editing process and identify calciumpermeable AMPA receptors containing Q/R-unedited GluR2 subunits as important to neurogenesis.
We initially observed that glutamate stimulation of cultured human NPCs led to a notable intracellular calcium spike and sought to identify the source of calcium. Removal of calcium from the medium of NPCs prevented the calcium spike, indicating an influx of extracellular calcium (data not shown). NMDA receptors are typically responsible for glutamate-induced calcium influx; however, the expression of NMDA receptors on neural precursors is still unclear (39) . Microarray analysis failed to identify any NMDA subunit mRNA, and Western blotting demonstrated the lack of NR1 subunit protein expression in our NPC culture (data not shown). This observation was validated by treatment with the NMDA receptor antagonist MK-801, which did not block calcium influx following stimulation with 100 M Glu (data not shown) or 100 M Glu and 10 M cyclo (Fig. 3C) , and 100 M NMDA failed to induce calcium response (data not shown). Having ruled out NMDA-dependent calcium influx, we investi- gated non-NMDA glutamate receptors on NPCs. The AMPA and kainate receptor antagonist CNQX completely blocked the glutamate-induced calcium influx (Fig. 3A, D) . To decipher whether this was a consequence of AMPA or kainate receptor activation, we used cyclo, an AMPA receptor-specific potentiator. Cyclo significantly enhanced glutamate-induced calcium influx (Fig. 3A, C, D) , supporting AMPA receptors as the primary source of the observed calcium spikes. Furthermore, the AMPA receptor-specific antagonist Joro spider toxin and its synthetic analog, Naspm, both blocked the glutamate-or AMPA-induced calcium influx (Fig. 3B, C) . The use of the AMPA-specific potentiator and antagonists demonstrates that the glutamateinduced calcium influx in NPCs is dependent on AMPA receptors.
Although AMPA receptor activation generally does not facilitate calcium influx, a variety of mechanisms could explain this phenomenon. Membrane depolarization due to sodium influx through AMPA receptors could remove the magnesium blockade from NMDA receptors or open voltage-gated calcium ion channels. However, the NMDA antagonist MK-801 did not prevent the glutamate-mediated calcium influx; further, the calcium ion channel blocker nimodipine had no effect (Fig. 3C, D) . AMPA assembly without the GluR2 subunit results in a higher-conductance channel that permits calcium entrance (8) . Low expression of GluR2 subunits leads to tetraheteromeric complexes lacking GluR2 and the presence of calcium-permeable AMPA receptors (40) . However, our cultures were found to express significant amounts of GluR2 subunits at levels comparable to GluR1 (Fig. 2A, F, G) . Cells expressing GluR2 may contain the occasional AMPA receptor lacking GluR2 incorporation (6, 41) , but this is unlikely to explain the high amounts of calcium influx observed. Thus, we hypothesized that the observed calcium influx in NPCs was due to the presence of AMPA receptors containing Q/R-unedited GluR2 subunits.
AMPA receptors are typically composed of GluR2 subunits that express an arginine at residue 607 (2, 3, 7) . This residue is actually genetically coded as a glutamine, but the pre-mRNA is edited, resulting in incorporation of an arginine. We found significant levels of Q/R-unedited GluR2 subunits in NPCs using an established restriction enzyme digestion protocol (13) to assay the Q/R editing status of GluR2. The expression ratio of Q/R-unedited GluR2 mRNA to edited mRNA was found to decrease as NPCs differentiated. The assay indicates roughly 60% of GluR2 mRNA is unedited in NPC cultures; whereas Q/Runedited mRNA is significantly reduced in both neuronal and glial cultures 4 wk later (Fig. 5C ). Given that our NPC culture is contaminated with ϳ5% differentiated cells (27) , the actual percentage of unedited GluR2 in NPCs may be even higher than indicated in Fig. 5C .
The enzyme responsible for editing GluR2 premRNA at the Q/R site is ADAR2 (10, 12, 13) . ADAR2 edits nearly 100% of GluR2 mRNA to the arginine encoding form. In support of our finding in NPCs, ADAR2 (42, 43) and Q/R editing (44) were previously shown to be upregulated during embryonic development, and, similarly, ADAR2 increases during differentiation (42, 43) . To confirm the role of calcium-permeable AMPA receptors with Q/R-unedited GluR2 in neuronal differentiation, we induced GluR2 Q/R editing in cultured NPCs. In lieu of overexpressing edited GluR2 subunits, we transfected NPCs with the ADAR2 enzyme to prematurely induce GluR2 editing. ADAR2 overexpression increased observed Q/R editing from ϳ50% to more than 90% (Fig. 8B) . Although CFP vector transfection had no effect on AMPA-induced differentiation to neurons (Fig. 8D) , ADAR2 overexpression in NPCs prevented AMPA-induced neuronal differentiation (Fig. 8F) . Cumulatively, these findings demonstrate that calcium-permeable AMPA receptors with Q/R-unedited GluR2 are responsible for glutamate-induced differentiation of NPCs to neurons.
Neurogenesis is the process of generating functionally integrated neurons from progenitor cells (45) . There are two paths of differentiation for NPCs: neurogenesis (neurons) and gliogenesis (astrocytes and oligodendrocytes). We used immunocytochemistry to evaluate NPC differentiation to ␤-tubulin-III ϩ neurons and to quantify dendritic arborization. Activation and/or potentiation of calcium-permeable AMPA receptors were found to enhance neuronal differentiation. Successful neurogenesis requires the generation of new neurons, as well as formation of functional interactions with other neurons. The potential of neurons to form connections can be quantified through measurement of arbors, neurites, and branch nodes, as we have described previously (30) . We found that stimulation of AMPA receptors on NPCs differentiated to neurons increased the number of arbors, neurites, and branch nodes per cell, indicating that AMPA receptor stimulation is important to forming synaptic connections and integration in the CNS. This was consistent with the prior finding that AMPA receptor potentiation increases neurite length (46) . Previous in vivo studies demonstrated that a gene-encoded arginine in the Q/R-editing site led to normal physiological functions and no gross anatomical defects (12, 47) . However, studies specifically investigating neurogenesis in these animals have not been reported.
Q/R editing of the GluR2 subunit is essential for survival, as demonstrated by the premature death of ADAR2 knockout mice (12) Furthermore, disruption of Q/R-editing propagates neurodegeneration in amyotrophic lateral sclerosis (ALS) (17) and ischemia (14) . The use of mRNA modification in favor of a gene-encoded arginine at the Q/R site is a unique biological circumstance. If this arrangement had no biological significance, mutation of a single nucleotide changing the CAG (Q) codon to a CGG (R) codon would have likely replaced this inefficient system. However, the presence of a gene-encoded glutamine and the Q/R-editing process is highly conserved (48) . Tracing back to the appearance of cartilaginous fish, the Q/R-editing process is conserved with very few exceptions (48, 49) , implying a strong selective pressure for calcium-permeable AMPA receptors with Q/R-unedited GluR2 subunits. Our results suggest a physiological role for calcium-permeable AMPA receptors with Q/Runedited GluR2 as a mechanism in neurogenesis.
Whether NPC differentiation is dependent on calcium influx in general or through AMPA-specific signaling is not clear. Calcium from AMPA receptor activation can increase BDNF transcription through calcium response elements on the BDNF promoter (24) . AMPA receptors physically associate with the tyrosine kinase Lyn. Lyn activation through AMPA receptors can stimulate mitogen-activated protein kinases (MAPK), leading to increased BDNF expression (24) . BDNF promotes neurogenesis in the CNS by promoting survival and differentiation of NPCs to a neuronal lineage (52, 53) . Further, AMPA receptors with Q/R-unedited GluR2 subunits are also permeable to zinc (50) , and this may be involved in differentiation (51) . Other mechanisms of AMPA-induced differentiation may include regulation of immediate early genes, such as, c-fos, c-jun, and NGFI-A (54) and basic helixloop-helix (bHLH) genes such as Mash1, Math, and Ngn that play critical roles in the regulation of neural stem cell differentiation (55, 56) . The intracellular signaling pathways responsible for the induction of NPC differentiation to neurons require further investigation.
Our findings further support the growing evidence that AMPA receptor potentiators may be a useful therapeutic tool to enhance neurogenesis and treat neurodegenerative disorders (23) (24) (25) (26) . AMPA receptor potentiators have been shown to enhance NPC proliferation in rodents (23) and to provide neuroprotective stimuli for neurons in vivo (24, 60) . Drugs such as 1-(quinoxalin-6-yl-carbonyl)piperidine (CX516) and LY451395 have been found to be well tolerated by adult humans, with minor adverse effects (24, (55) (56) (57) . This therapeutic avenue may provide a safe intervention to protect neurons and to promote neurogenesis in the setting of neurodegenerative disorders.
